The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2025 for Raksha Sudhir Valia
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raksha Sudhir Valia, a person acting in concert with the promoter group of Sun Pharmaceutical Industries, released a pledge on 50,000 equity shares on September 4, 2025. The shares had been pledged with Aditya Birla Finance Limited as security for a loan availed by a third party (not by Valia herself). After this release, her encumbered shares stand at 1,25,90,000 (0.525% of total share capital), down from 1,26,40,000 (0.527%) earlier. Her total holding in Sun Pharma remains at 28,830,352 shares (1.20% of share capital), with no change in overall ownership. The release is very small in size relative to her total stake and the company's share base.
This is a routine, minor pledge release involving only 50,000 shares (0.002% of capital) and does not change Raksha Valia's actual shareholding in Sun Pharma. It is unlikely to have any meaningful impact on the stock price or shareholder concerns, as it simply unwinds a third-party collateral arrangement.